ArticleCurrent cancer drug targets2024

IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration.

Wei Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.